Orphan drugs and where to launch them: The keys to Europe’s forgotten territories
Pharmaceutical Technology
JULY 14, 2022
Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The
59 
Let's personalize your content